Effects of defoliant exposure and medication use on the development of Parkinson’s disease in veterans
Age and Ageing · 2023
DOI: 10.1093/ageing/afad192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Age and Ageing, 2023. Verfasst von Seulki Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy & Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Parkinson Disease, Veterans, Parkinson Disease, Secondary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: VHS Medical Center Research Grant.
Abstract (Originalsprache)
Background
Vietnam-era veterans were exposed to Agent Orange (AO), which is associated with a high prevalence of Parkinson’s disease (PD). However, little is known about the development of PD-like symptoms caused by drug-induced parkinsonism (DIP) in such populations. This study aimed to investigate PD incidence and PD risk following exposure to AO or DIP-risk drugs in veterans.
Methods
A retrospective cohort study was conducted using 12 years (2009–2020) of electronic medical records of the Veterans Health Service Medical Center, the largest Veterans Affairs hospital in South Korea (n = 37,246; 100% male; age, 65.57 ± 8.12 years). Exposure to AO or DIP-risk drugs, including antipsychotic, prokinetic, anti-epileptic, dopamine-depleting and anti-anginal agents, was assessed in veterans with PD, operationally defined as having a PD diagnosis and one or more prescriptions for PD treatment. The PD risk was calculated using multiple logistic regression analysis adjusted for age and comorbidities.
Results
The rates of DIP-risk drug use and AO exposure were 37.92% and 62.62%, respectively. The PD incidence from 2010 to 2020 was 3.08%; 1.30% with neither exposure, 1.63% with AO exposure, 4.38% with DIP-risk drug use, and 6.33% with both. Combined exposure to AO and DIP-risk drugs increased the PD risk (adjusted odds ratio = 1.68, 95% confidence interval, 1.36–2.08, P < 0.001).
Conclusions
The PD incidence was 1.31 times higher with AO exposure alone and 1.68 times higher with AO exposure and DIP-risk drug use. The results suggest the necessity for careful monitoring and DIP-risk drug prescription in patients with AO exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy & Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
- Department of Pharmacy, Veterans Health Service Medical Center, Seoul, Republic of Korea.
- Department of Physical Medicine and Rehabilitation, Hanyang University Medical Center, Seoul, Republic of Korea.
- Veterans Medical Research Institute, Veterans Health Service Medical Center, Seoul, Republic of Korea.
- Department of Applied Statistics, Chung-Ang University, Seoul, Republic of Korea.
- College of Pharmacy, Dankook University, Cheonan, Republic of Korea.
Förderung
- VHS Medical Center Research Grant
Zitieren
APA
Song, S., Kim, J. Y., Lee, Y., Jeong, H., Kim, S., & Lee, E. E. (2023). Effects of defoliant exposure and medication use on the development of Parkinson’s disease in veterans. Age and Ageing. https://doi.org/10.1093/ageing/afad192
Vancouver
Song S, Kim JY, Lee Y, Jeong H, Kim S, Lee EE. Effects of defoliant exposure and medication use on the development of Parkinson’s disease in veterans. Age and Ageing. 2023. doi:10.1093/ageing/afad192
BibTeX
@article{Song2023,
author = {Song, Seulki and Kim, Jun Y and Lee, Young and Jeong, Hyokeun and Kim, Seungyeon and Lee, Eunkyung E},
title = {Effects of defoliant exposure and medication use on the development of Parkinson’s disease in veterans},
journal = {Age and Ageing},
year = {2023},
doi = {10.1093/ageing/afad192}
}
EUVIMED